Ping An Biomedical Co., Ltd. (PASW) Stock Score, Valuation & Financial Research

Ping An Biomedical Co., Ltd. is in the Industrials sector and Manufacturing - Textiles industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for PASW

Ping An Biomedical Co., Ltd. does not currently have a complete Wall Street Score. The stored market price is USD 0.12. These figures are a research snapshot, not a buy or sell recommendation.

What Ping An Biomedical Co., Ltd. does

Ping An Biomedical Co., Ltd. delivers comprehensive supply chain management services tailored for the clothing sector. The company furnishes integrated solutions to its clients, covering a wide spectrum of offerings from initial yarn products and various textiles to fully manufactured garments. Its operations are organized into two primary divisions: Yarns and Finished Garments. Established in 2013 by Yuk Yin Li and Sek Yan Ko, the firm's main office is situated in Hong Kong.

Company business and revenue

Research reporting period: 2025-09-30. A research update is not a new financial filing.

How the company makes money

Ping An Biomedical Co., Ltd. operates as a supply chain management service provider in the apparel industry, offering market trend analysis, product design, raw material sourcing, production, quality control, and logistics. The company also engages in the manufacturing and trading of yarns, textiles, and finished garments, alongside property investment and warehousing services.

Products and services

  • Supply chain management services for apparel, manufacturing and trading of yarns, textiles, and finished garments, real estate property investment, and warehousing services.

Customer types

Brand owners; Textile manufacturers; Apparel sourcing agents; Online fashion and garment retailers.

Suppliers, materials and equipment

  • Textile and raw material manufacturers — The company sources raw materials and textiles from various third-party manufacturers to support its supply chain and production operations. Source

Business strengths to evaluate

  • Integrated supply chain management capabilities across multiple international markets Source

Business risks and research considerations

  • Operational and legal risks associated with conducting business in China while being incorporated in the Cayman Islands Source
  • Difficulties in enforcing foreign judgments or serving process in China Source

Sources: Company research source

Company research refreshed 2026-10-13. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

PASW financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 0.12
Market capitalization:
2.22M (currency not supplied)
Revenue:
USD 5.1M
Net income:
USD -1.91M
Free cash flow:
USD -959.32K
Cash:
USD 174.99K
Total debt:
USD 1.56M
EPS:
USD -0.10

What stands out

  • Reported year-over-year revenue growth is -61.0%.
  • Free cash flow is USD -959.32K, negative for the stored period.
  • The balance sheet shows USD 174.99K of cash versus USD 1.56M of total debt, with debt exceeding cash on these two reported measures.
  • The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Free cash flow is -18.8% of stored revenue. This is a simple cross-field ratio, not a verified same-period cash conversion margin; confirm reporting periods before comparison.
  • Net income equals -37.6% of stored revenue. This is an indicative ratio only; accounting periods and units should be verified in filings.
  • Debt exceeds cash by USD 1.39M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for PASW

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • What is driving PASW's revenue decline, and does the latest filing suggest the weakness is temporary or structural?
  • How long can PASW fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • Is PASW's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • What specifically needs to improve for PASW to reach sustainable profitability?
  • What does the current share basis reconciled warning mean for the reliability or interpretation of PASW's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-12.

Research-input completeness: 82% of the scoring inputs required for this public page are currently available.

How to research PASW

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.